 NEW YORK, May 10, 2021 GLOBE NEWSWIRE -- Eyenovia, Inc. NASDAQ: EYEN, a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print MAPTM therapeutics, today announced that the company has entered into a new 25 million credit financing facility with Silicon Valley Bank SVB. 